VBI Vaccines Updates Share Sale Agreements and Partnerships
Company Announcements

VBI Vaccines Updates Share Sale Agreements and Partnerships

VBI Vaccines (VBIV) has issued an update.

VBI Vaccines Inc. has engaged with H.C. Wainwright & Co. to potentially sell up to $8,468,289 worth of common shares in an at-the-market offering, following a registration statement effective since September 2022. The company could use the proceeds for general corporate purposes, with Wainwright earning a 3% commission on sales. This new agreement follows the termination of a previous arrangement with Jefferies LLC, which could have seen sales up to $125 million, and carries no penalties for the company.

See more data about VBIV stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyBiotech Alert: Searches spiking for these stocks today
TheFlyBiotech Alert: Searches spiking for these stocks today
TheFlyThree new option listings and two option delistings on August 8th
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App